Science and medicine, scientist analyzing and dropping a sample into a glassware, experiments containing chemical liquid in laboratory on glassware, DNA structure, innovative and technology.
Overview
The CRG is Austria’s first funding programme in the field of non-commercial disease- and patient-oriented (translational), collaborative clinical research.
The Call
Latest information
The call platform eSubmission is open for submission.
An information webinar will take place on the 17 September 2026. Please sign up here to participate.
To receive the latest information by email, please subscribe to our updates here.
LBG offers a new call for Clinical Research Groups in the field of Women’s Health and Gender Medicine.
Clinical research projects on women’s health and gender medicine will be funded across all life phases of women and girls. This reflects a holistic understanding of the health of women and girls, with a focus on tangible improvements in the treatment and care of female patients.
Women’s health and gender medicine encompasses clinical questions relating to sex- and gender-specific differences in prevention, symptomatology, short- and long-term diagnostics, and the treatment of physical and mental conditions across the entire lifespan.
This includes gynecological conditions (e.g. endometriosis) as well as topics such as menstrual health, sexual and reproductive health, the peri-, meno-, and post-menopause, and questions around healthy aging.
Also included are cardiovascular, oncological, neurological, psychiatric, immunological, endocrinological, metabolic, and other chronic conditions, as well as aspects of drug safety and/or efficacy and precision medicine. The gendered realities of health and illness in everyday life are to receive particular attention in this context.
Alongside the clinical research projects, life-phase-oriented approaches, digital medicine, aspects of health services research, intersectionality, and gender diversity may also be taken into consideration.
Important dates
- Publication of call documents: 30 June 2026
- Deadline for short proposals: 6 November 2026
- Deadline for full proposals (by invitation only): 9 April 2027
- Interviews: June 2027
- Start of the Clinical Research Group: 1 January 2028
Forms on the website (“Downloads”) are intended for preparing the application only, not for submission. From the opening of the call, applications may be submitted exclusively via the LBG eSubmission portal eSubmission.
Webinar
A webinar with information for applicants will take place in autumn 2026. Information and the option to register will be made available here in September 2026.
Scientific Remit
The call for proposals for LBG Clinical Research Groups (CRG) aims to fund medium-term, collaborative research programs with a clear focus on patient-oriented, medically relevant topics in the field of non-commercial clinical research. In line with the current government program (2025–2029), this year’s call focuses on women’s health research and gender medicine.
Support is provided for the development of innovative research findings in disease- or patient-oriented clinical research within the framework of investigator-initiated clinical trials, with the possibility of integrating translational aspects. At the same time, in the spirit of early-career development, high-quality training opportunities are to be offered to young clinical researchers.
The CRG shall address a coherent research program consisting of several work packages/sub-projects. The following requirements must be met:
- innovative and high quality in the field of disease- or patient-oriented clinical research and the development of diagnostic or therapeutic methods, science communication, and target-group-specific public outreach;
- at least 50% of the planned work must be carried out at medical universities/faculties;
- includes investigator-initiated clinical trials (Phase I–III) or other non-commercial clinical trials in combination with clinical pilot or accompanying studies (observational studies, longitudinal studies, epidemiological studies, biobanking, biomarker studies, patient outcome studies, proof of concept studies, etc.);
- complies with Good Clinical Practice standards;
- demonstrates an interdisciplinary, synergistic, and collaborative nature between clinical and non-clinical members, thereby making a particular contribution to improving cooperation (synergies) between medical institutions;
- promotes early-career researchers and addresses gender equality issues.
Eligibility
The main applicant of a CRG, the Lead Institution, must be an Austrian medical university/faculty with an affiliated university hospital.
The application for a Clinical Research Group must be submitted by an Austrian medical university/faculty with an affiliated university hospital, acting as the Lead Institution on behalf of several cooperation partners.
Cooperation partners may include public or private universities, universities of applied sciences, hospitals and/or non-university research institutions in the non-profit sector. Together with the Lead Institution, these partners are funding recipients.
Commercial cooperation partners are also possible, although they are not funding recipients.
CRG Composition
A CRG comprises of the following personnel:
- one Mentor*,
- one Head*,
- one or more Sub-Project Manager(s), of which one or more Deputy Head(s)* have to be appointed, as well as
- researchers and additional team members.
* employed at Lead Institution
Funding Volume and Duration
- Call budget 2026/27: EUR 8.32 million
- Funding:
EUR 0.52–1.04 million per annum
A maximum of 90% of the total costs of the Clinical Research Group will be funded.
Participating institutions must contribute at least 10% of the Clinical Research Group costs from their own resources. - Duration: 4 + 4 years, with the second funding period subject to a successful interim evaluation.
Selection Process
Two-stage selection procedure: Short proposals are evaluated by a scientific expert committee, which selects applicants to submit full proposals. The full proposals are then subject to peer review, after which applicants are invited to on-site interviews with the scientific expert committee.
Scientific Expert Commission
The scientific expert committee provides strategic and operational support for programme development and the review process and is composed of high-ranking, internationally recognised scientific experts. The members of the committee will be announced here.
Application Process
All information and documents are provided on this webpage.
Please check regularly for updates.
The call will be available on eSubmission shortly. Please the use the short proposal application form to prepare accordingly.
Online Application Portal
Further Information and Contact
Programme Management – Clinical Research Groups
Neda Motamedi-Shad, PhD
Telefon: +43 (0) 1 513 27 50-45
Bettina Lengger, PhD
Telefon: +43 (0) 1 513 27 50-71
Mail: xst@yot.np.ng



